Allogeneic class I MHC requirement for alloantigen-reactive helper T- lymphocyte responses in vivo: Evidence for indirect presentation of alloantigen

Transplantation

Volumn 62, Issue 3, 1996, Pages 388-396

  Clement, Jeffrey D ^a,b   Chan, Sherri Y ^c   Bishop, D Keith ^c,d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; HELPER CELL; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029824280     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199608150-00015     Document Type: Article

References (46)

1. Shoskes DA, Wood KJ. Indirect presentation of MHC antigens in transplantation. Immunol Today 1994; 15: 32.
2. Bradley JA, Mowat AM, Bolton EM. Processed MHC class I alloantigen as the stimulus for CD4+ T-cell dependent antibody-mediated graft rejection. Immunol Today 1992; 13: 434.
3. Sayegh MH, Watschinger B, Carpenter CB. Mechanisms of T cell recognition of alloantigen: the role of peptides. Transplantation 1994; 9: 1295.
4. Lechler RI, Lombardi G, Batchelor JR, Reinsmoen N, Bach FH. The molecular basis of alloreactivity. Immunol Today 1990; 11: 83.
5. DeKoster HS, Anderson DC, Termijtelen A. T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP. J Exp Med 1989; 169: 1191.
6. Via CS, Tsokos GC, Stocks NI, Clerici M, Shearer GM. Human in vitro allogeneic responses: demonstration of three pathways of T helper cell activation. J Immunol 1990; 144: 2524.
7. Chen BP, Madrigal A, Parham P. Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule. J Exp Med 1990; 172: 779.
8. Liu Z, Braunstein NS, Suciu-Foca N. T cell recognition of allopeptides in context of syngeneic MHC. J Immunol 1992; 148: 35.
9. - hepatocytes. Transplantation 1992; 53: 863.
10. Liu Z, Sun Y-K, Xi Y-P, Maffei A, Reed E, Harris P, Suciu-Foca N. Contribution of direct and indirect recognition pathways to T cell alloreactivity. J Exp. Med 1993; 177: 1643.
11. Gracie JA, Bolton EM, Porteous C, Bradley JA. T cell requirements for the rejection of renal allografts bearing an isolated class I MHC disparity. J Exp. Med 1990; 172: 1547.
12. Dalchau R, Fangmann J, Fahre JW. Allorecognition of isolated, denatured chains of class I and class II major histocompatibility complex molecules. Evidence for an important role for indirect allorecognition in transplantation. Eur. J Immunol 1992; 22: 669.
13. Sawyer GJ, Dalchau R, Fabre JW. Indirect T cell allorecognition: A cyclosporin A resistant pathway for T cell help for antibody production to donor MHC antigens. Transplant Immunol 1993; 1: 77.
14. Lee RS, Grusby MJ, Glimcher LH, Winn HJ, Auchincloss H Jr. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J Exp. Med 1994; 179: 865.
15. Bishop DK, Shelby J, Eichwald EJ. Mobilization of T lymphocytes following heterotopic cardiac transplantation: Evidence that CD4 positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection. Transplantation 1992; 53: 849.
16. Bishop DK, Chan SY, Li W, Ensley RD, Xu S, Eichwald EJ. CD4-positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes. Transplantation 1993; 56: 892.
17. Bishop DK, Li W, Chan SY, Ensley RD, Shelby J, Eichwald EJ. Helper T lymphocyte unresponsiveness to cardiac allografts following transient depletion of CD4 positive cells: Implications for cellular and humoral responses. Transplantation 1994; 58: 576.
18. Forbes RDC, Parfrey NA, Gomersall M, Darden AG, Guttmann RD. Dendritic cell-lymphoid cell aggregation and major histocompatibility antigen expression during rat cardiac allograft rejection. J Exp. Med 1986; 164: 1239.
19. Ijzermans JN, Bouwman E, van der Meide PH, Jeekel J, Marquet RL. Increase of major histocompatibility complex class II-positive cells in cardiac allografts by Interferon-γ has no impact on graft survival. Transplantation 1989; 48: 1039.
20. Forbes RDC, Gomersall M, Darden AG, Guttmann RD. Multiple patterns of MHC class II antigen expression on cellular constituents of rat heart grafts: Lack of correlation with graft survival, but strong correlation with vasculitis. Transplantation 1991; 51: 942.
21. Bishop DK, Jutila MA, Sedmak DD, Beattie MS, Orosz CG. Lymphocyte entry into inflammatory tissues in vivo: Qualitative differences of high endothelial venule-like vessels in sponge matrix allografts vs isografts. J Immunol 1989; 142: 4219.
22. Bishop DK, Li W. Cyclosporin A and FK506 mediate differential effects on T cell activation in vivo. J Immunol 1992; 148: 1049.
23. Bishop DK, Ferguson RM, Orosz CG. Differential distribution of antigen specific helper T cells and cytotoxic T cells following antigenic stimulation in vivo: A functional study using limiting dilution analysis. J Immunol 1990; 144: 1153.
24. Sirinek LP, Zinn NE, Ferguson RM, Orosz CG. in vivo mechanisms of alloreactivity: III. Development of donor-specific antibody in sponge matrix allografts. Transplantation 1986; 41: 349.
25. Koller BH, Marrack P, Kappler JW, Smithies O. Normal development of mice deficient in β2 M, MHC class I proteins, and CD8+ T cells. Science 1990; 248: 1227.
26. Bishop DK, Orosz CG. Limiting dilution analysis for alloreactive, TCGF-secreting T cells: LDA methods that discriminate between unstimulated precursor T cells and in vivo alloactivated T cells. Transplantation 1989; 47: 671.
27. Ryser JE, MacDonald HR. Limiting dilution analysis of alloantigen-reactive T lymphocytes. I. Comparison of precursor frequencies for proliferative and cytolytic responses. J Immunol 1979; 122: 1691.
28. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol 1981; 126: 1614.
29. Steinmuller D. Which T cells mediate allograft rejection? Transplantation 1985; 20: 229.
30. Hall B. Cells mediating allograft rejection. Transplantation 1991; 51: 1141.
31. Rosenberg AS, Singer A. Cellular basis of skin allograft rejection: An in vivo model of immune-mediated tissue destruction. Annu Rev Immunol 1992; 10: 333.
32. Lafferty KJ, Prowse SJ, Simeonovic CJ. Immunobiology of tissue transplantation: A return to the passenger leukocyte concept. Annu Rev Immunol 1983; 1: 143.
33. k antigens by lymphoid cells. Transplantation 1982; 33: 36.
34. Davies HffS, Pollard SG, Calne RY. Soluble HLA antigens in the circulation of liver graft recipients. Transplantation 1989; 47: 524.
35. DeVito-Haynes LD, Jankowska-Gan E, Knechtle SJ, Burlingham WJ. Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific, soluble HLA class I. Hum. Immunol 1992; 40: 191.
36. Sherwood RA, Brent L, Rayfield LS. Presentation of alloantigens by host cells. Eur. J Immunol 1986; 16: 569.
37. Benichou G, Takizawa PA, Olson CA, McMillan M, Sercaz EE. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J Exp. Med 1992; 175: 305.
38. Watschinger B, Gallon L, Carpenter CB, Sayegh MH. Mechanisms of allo-recognition: Recognition by in vivo-primed T cells of specific major histocompatibility complex polymorphisms presented as peptides by responder antigen-presenting cells. Transplantation 1994; 57: 572.
39. Benham A, Fabre JW. Fine specificity of peptide determinants for indirect T cell recognition of class I MHC alloantigens. Transplantation 1994; 58: 1236.
40. Gallon L, Watschinger B, Murphy B, Akalin E, Sayegh MH, Carpenter CB. The indirect pathway of allorecognition: The occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression. Transplantation 1995; 59: 612.
41. Schwartz RH. T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex. Annu Rev Immunol 1985; 3: 237.
42. Auchincloss H Jr., Lee R, Shea S, Markowitz JS, Grusby MJ, Glimcher LH. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc. Natl. Acad. Sci. USA 1993; 90: 3373.
43. Bishop DK, DeBruyne LA, Chan S, Xu S, Eichwald EJ. Dissociation of mouse cardiac transplant rejection and donor alloantigen-specific T cell responsiveness. Transplant Immunol 1995; 3: 222.
44. b mutant mice: Differences in the immunogenic expression of the mutated molecule on thyroids of six different mutants. Transplantation 1983; 36: 571.
45. b mutant skin allografts differing at class I MHC. Nature 1986; 322: 829.
46. Steele DJR, Laufer T, Smiley S, Ando Y, Grusby MJ, Glimcher LH, Winn HJ, Auchincloss H Jr. Two levels of help for B cell alloantibody production J Exp. Med 1996; 183: 699.